These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Modified VAPA therapy in children with acute nonlymphocytic leukemia]. Morohashi F; Aonuma K; Katoh M; Kobayashi T; Hanaoka Y; Tsuji K; Norose N; Kawai H; Nakahata T; Tsukada M Rinsho Ketsueki; 1986 Nov; 27(11):2101-6. PubMed ID: 3820627 [No Abstract] [Full Text] [Related]
13. Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly. Kahn SB; Begg CB; Mazza JJ; Bennett JM; Bonner H; Glick JH J Clin Oncol; 1984 Aug; 2(8):865-70. PubMed ID: 6379120 [TBL] [Abstract][Full Text] [Related]
14. High-dose cytosine arabinoside and daunomycin as primary therapy for adults with acute nonlymphoblastic leukemia: a pilot study. Forman SJ; Nademanee AP; O'Donnell MR; Fahey JL; Snyder DS; Farbstein MJ; Lazar GS; DuBois NJ; Blume KG Semin Oncol; 1985 Jun; 12(2 Suppl 3):114-6. PubMed ID: 4012336 [No Abstract] [Full Text] [Related]
15. [High-dose treatment]. Takaku F Gan To Kagaku Ryoho; 1985 Apr; 12(4):830-8. PubMed ID: 3872631 [TBL] [Abstract][Full Text] [Related]
16. High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia. Chan HY; Meyers FJ; Lewis JP Cancer Chemother Pharmacol; 1987; 20(3):265-6. PubMed ID: 3677301 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide. Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446 [TBL] [Abstract][Full Text] [Related]
18. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia]. Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393 [No Abstract] [Full Text] [Related]
19. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial). Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851 [TBL] [Abstract][Full Text] [Related]
20. The use of amsacrine plus intermediate-dose cytosine arabinoside in relapsed and refractory acute nonlymphocytic leukemia. Dekker AW; Punt K; Verdonck LF Haematol Blood Transfus; 1987; 30():333-5. PubMed ID: 3623240 [No Abstract] [Full Text] [Related] [Next] [New Search]